Diagnostic HormonesSecreFlo (secretin) Injection
Manufacturer: ChiRhoClin, Inc.
Drug Approval Classification: Supplemental New Drug Application (Approval Date: 11/1/02)
New Indication: SecreFlo is now indicated for use in secretin stimulation testing for the stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangio-pancreatography (ERCP).
Dosing: To facilitate the identification of the ampulla of Vater and during ERCP, the recommended dose is 0.2 mcg/kg body weight by intravenous injection over 1 minute.
Medscape Pharmacists. 2002;3(2) © 2002 Medscape
Cite this: December 2002 - Medscape - Dec 30, 2002.